Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.0105 (5.83%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £2.52m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Interim Results

26 Sep 2006 16:46

Azure Holdings PLC26 September 2006 Azure Holdings Plc (" Company") Interim results for the six months ended 30 June 2006 Chairman's statement I am pleased to present the interim accounts for the six months ended 30 June2006. In the six months to 30 June 2006 the Company announced a loss after taxation of£138,000 (2005: £74,000). The figures should not reflect the future of the Company, which hopefully willmove forward successfully as ValiRx plc from early next month, because, asannounced on 11 September 2006, the reverse acquisition of ValiRx Limited hasbeen agreed and is subject to shareholders approval at the EGM scheduled for 2October 2006. If all the resolutions at that meeting are approved, the Company will retain itsAIM quotation and I will resign as Chairman leaving the new board and GerryDesler, Finance Director from the old board, to run the Company. Barry GoldChairman 26 September 2006 Azure Holdings plc Profit and Loss Account for the six months ended 30 June 2006 6 months ended 6 months ended Year ended 31 30 June 2006 30 June 2005 December 2005 (unaudited) (unaudited) (audited) £'000 £'000 £'000 Turnover - - - Administrative expenses (138) (74) (134) Operating loss (138) (74) (134) Loss on ordinary activities before taxation (138) (74) (134) Tax on loss on ordinary activities - - - Loss on ordinary activities after taxation (138) (74) (134) Retained loss for the period (138) (74) (134) Loss per ordinary share (0.12p) (0.15p) (0.28p) The profit and loss account has been prepared on the basis that all operationsare continuing operations. All recognised gains or losses are dealt withthrough the profit and loss account or statement of recognised gains and losses. Azure Holdings plc Balance Sheet as at 30 June 2006 30 June 2006 30 June 2005 31 December 2005 (unaudited) (unaudited) (audited) £'000 £'000 £'000Current assetsDebtors 9 3 1Cash at bank and in hand 127 1 1 136 4 2 Creditors: amounts falling due within one year (103) (147) (205) Net current assets/(liabilities) 33 (143) (203) Total assets less current liabilities 33 (143) (203) Net (liabilities)/assets 33 (143) (203) Capital and reservesCalled up Share Capital 6,271 5,475 5,475Share Premium 9,858 10,279 10,279Profit and loss account (16,096) (15,897) (15,957) Equity shareholders funds 33 (143) (203) Azure Holdings plc Cash Flow Statement for the six months ended 30 June 2006 6 months ended 6 months ended 30 June 2006 30 June 2005 (unaudited) (unaudited) £'000 £'000Net cash inflow (outflow) from operating activities (249) (13) FinancingIssue of ordinary shares 796 - Share premium reduction arising onconversion of loan stock (421) - Increase/(Decrease) in cash 126 (13) Azure Holdings plc Notes to the Interim Results 1. The interim results are unaudited and do not constitute statutoryaccounts within the meaning of section 240 of the Companies Act 1985. Thefigures for the year ended 31 December 2005 have been extracted from thestatutory accounts filed with the registrar of companies on which the auditorsgave an unqualified report. 2. The interim results have been prepared using the accountingpolicies set out in the statutory accounts for the year ended 31 December 2005. 3. The comparative figures for the unaudited interim results for theperiod ended 30 June 2005 are stated as announced on 27 September 2005. 4. Loss per share The loss per share for the six months ended 30 June 2006 has been calculated onthe basis of the loss after taxation for the period of £138,000 (2005: £74,000) and the weighted average number of shares in issue during the period of118,717,810 (2005: 48,317,569). . 5. The directors do not propose to pay a dividend for the period. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Oct 20147:00 amRNSApproved Clinical Trial Update
8th Oct 20144:12 pmRNSEarly Completion of Equity Swap Agreement
8th Oct 20144:08 pmRNSHolding(s) in Company
2nd Sep 20147:00 amRNSValiSeek Development Update
28th Aug 201411:33 amRNSHolding(s) in Company
19th Aug 20147:00 amRNSHalf Yearly Report
5th Aug 201412:05 pmRNSHolding(s) in Company
4th Aug 20147:00 amRNSNotice of Acceptance of CTA Request
1st Jul 201411:35 amRNSHolding(s) in Company
24th Jun 20147:00 amRNSDirector/PDMR Shareholding
18th Jun 20149:22 amRNSNew Corporate Website & New Office Address
10th Jun 20147:00 amRNSSubmission of Clinical Trial Application re VAL201
15th May 20147:00 amRNSValiSeek Development Update
1st May 20147:00 amRNSNew Japanese Patent Grant
23rd Apr 20144:29 pmRNSResult of AGM
17th Apr 20145:51 pmRNSHolding(s) in Company
8th Apr 20147:00 amRNSValiSeek Joint Venture
1st Apr 20147:00 amRNSVAL201 Update
31st Mar 20144:45 pmRNSNotice of AGM
31st Mar 20144:09 pmRNSHolding(s) in Company
28th Mar 20147:01 amRNSPosting of R&As and Notice of AGM
19th Mar 20147:00 amRNSFinal Results
20th Feb 20147:00 amRNSNew European Patent Grant
31st Jan 201412:45 pmRNSSale of shares in VolitionRx
22nd Jan 20143:00 pmRNSGrant of Options
16th Jan 20147:00 amRNSIssue of Equity
27th Dec 20137:00 amRNSFundraising and Equity Swap
5th Dec 20137:00 amRNSNew Australian Patent Grant
28th Nov 20137:00 amRNSUpdate re Positive VAL201 & Biomarker Unit Studies
15th Nov 20137:00 amRNSPlacing to raise £1m
1st Nov 20137:00 amRNSChange of Broker
24th Oct 20134:25 pmRNSRe: VAL201 - Update
8th Oct 20137:00 amRNSDirectorate Changes
5th Sep 20137:00 amRNSHalf Yearly Report
15th Aug 20137:00 amRNSConsortium incl. ValiRx Awarded Eurostars Grant
31st Jul 20137:00 amRNSUpdate
25th Jun 20137:00 amRNSInvestor Presentation in Manchester
18th Jun 20134:11 pmRNSManchester One2One Investors Forum - June 26
13th Jun 20137:00 amRNSRe: VAL201 Update
6th Jun 201310:00 amRNSValiRx admitted as founder member of the SSE
25th Apr 20137:00 amRNSNew Patent Granted
22nd Apr 201311:52 amRNSResult of AGM
2nd Apr 20137:00 amRNSUpdate on Developmental and Clinical Activity
28th Mar 20137:01 amRNSFinal Results
21st Feb 20137:00 amRNSRe Commercial Development Update
23rd Jan 20137:00 amRNSAppointment of Medical Monitoring Officer
31st Dec 20127:00 amRNSTotal Voting Rights
22nd Nov 20127:00 amRNSRe: Update
19th Nov 201212:19 pmRNSResult of General Meeting
1st Nov 20121:49 pmRNSPlacing and Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.